RHOA and COVID-19: A recent study demonstrated that small GTPase RhoA activation drives increased cellular glycolytic capacity (Wu et al., 2021) which is typically associated with reduced mitochondrial metabolism; this result is also in agreement with the upregulation of Rho GTPase and disrupted mitochondrial function in COVID-19 patients.